Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1952 1
1972 4
1973 1
1981 1
1986 8
1987 12
1988 13
1989 11
1990 10
1991 11
1992 22
1993 19
1994 22
1995 23
1996 24
1997 24
1998 26
1999 36
2000 41
2001 70
2002 80
2003 113
2004 132
2005 164
2006 199
2007 198
2008 272
2009 325
2010 406
2011 517
2012 527
2013 607
2014 675
2015 676
2016 708
2017 700
2018 762
2019 885
2020 1054
2021 1068
2022 1041
2023 1077
2024 430

Text availability

Article attribute

Article type

Publication date

Search Results

11,497 results

Results by year

Filters applied: . Clear all
The following term was not found in PubMed: Eunnyeong
Page 1
Efgartigimod: First Approval.
Heo YA. Heo YA. Drugs. 2022 Feb;82(3):341-348. doi: 10.1007/s40265-022-01678-3. Drugs. 2022. PMID: 35179720 Free PMC article. Review.
Fibrodysplasia ossificans progressiva: diagnosis, management, and therapeutic horizons.
Pignolo RJ, Shore EM, Kaplan FS. Pignolo RJ, et al. Pediatr Endocrinol Rev. 2013 Jun;10 Suppl 2(0 2):437-48. Pediatr Endocrinol Rev. 2013. PMID: 23858627 Free PMC article. Review.
Fibrodysplasia ossificans progressiva (FOP), a rare and disabling genetic condition characterized by congenital malformations of the great toes and progressive heterotopic endochondral ossification (HEO) which is the most catastrophic of HEO disorders in humans. ... …
Fibrodysplasia ossificans progressiva (FOP), a rare and disabling genetic condition characterized by congenital malformations of the great t …
Zuranolone: First Approval.
Heo YA. Heo YA. Drugs. 2023 Nov;83(16):1559-1567. doi: 10.1007/s40265-023-01953-x. Drugs. 2023. PMID: 37882942 Review.
Joseon physician Heo Joon's Smallpox Medicine and 'Syndrome differentiation'.
Oh C. Oh C. Uisahak. 2021 Apr;30(1):35-68. doi: 10.13081/kjmh.2021.30.35. Uisahak. 2021. PMID: 34010848 Free PMC article. Review. English.
Next, I compared the medical cases of smallpox left behind by physicians before and after Heo Joon, so as to shed light on the meaning Heo Joon's smallpox medicine has in the history of medicine. ...Heo Joon did not know about the pathology, causes of the sma …
Next, I compared the medical cases of smallpox left behind by physicians before and after Heo Joon, so as to shed light on the meanin …
Sotrovimab: First Approval.
Heo YA. Heo YA. Drugs. 2022 Mar;82(4):477-484. doi: 10.1007/s40265-022-01690-7. Drugs. 2022. PMID: 35286623 Free PMC article. Review.
Omidubicel: First Approval.
Heo YA. Heo YA. Mol Diagn Ther. 2023 Sep;27(5):637-642. doi: 10.1007/s40291-023-00662-1. Epub 2023 Jun 24. Mol Diagn Ther. 2023. PMID: 37354365 Review.
Satralizumab: First Approval.
Heo YA. Heo YA. Drugs. 2020 Sep;80(14):1477-1482. doi: 10.1007/s40265-020-01380-2. Drugs. 2020. PMID: 32797372 Free PMC article. Review.
11,497 results
You have reached the last available page of results. Please see the User Guide for more information.